PCOS: References & Support
The UK Polycystic Ovary Syndrome support group is called Verity. Click here to see their website.
References
Balen HA, Braat DDM, West C, Patel A & Jacobs HS. Cumulative conception and live birth rates after the treatment of anovulatory infertility. An analysis of the safety and efficacy of ovulation induction in 200 patients. Hum Reprod 1994; 9: 1563-70
Li TC, Saravelos H, Chow MS, Chisabingo R & Cooke ID. Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovary syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 1998; 105: 338-44 Balen A.
Surgical management of polycystic ovary syndrome: pros and cons. The Obstetrician & Gynaecologist. 2000; 3: 17-20
Kim LH, Taylor AE & Barbieri RL. Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility? Fertil Steril 2000; 6:
Nestler JE, Jakubowicz DJ, Evans WS & Pasquali R. Effects of metformin on spontaneous ovulation and clomiphene-induced ovulation in the polycystic ovary syndrome. New Engl J Med. 1998; 338: 1876-80
Pasquali R, Atenucci D, Casimirri F et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989; 68: 173-9
Morin-Papunen LC, Koivunen RM, Ruokonen A & Martikainen HK. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril 1998; 69: 691-96
Utiger RD. Insulin and the Polycystic Ovary Syndrome. New Engl J Med 1996; 335: 657-8 Balen A. Pathogenesis of polycystic ovary syndrome – the enigma unravels? Lancet 1999; 354: [18 September]
Nestler JE. Polycystic ovary syndrome: a disorder for the generalist. Fertil Steril 1998; 70: 811-12 Pirwany IR, Yates RWS, Cameron IT & Fleming R. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women. Human Reprod 1999; 14: 2963-68
Acien P, Quereda F, Matall P et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome; a heterogenous group of disorders. Fertil Steril 1999; 72: 32-40
Sattar N, Hopkinson ZEC & Greer IA. Insulin-sensitising agents in polycystic ovary syndrome. Lancet 1998; 351: [31 January]
Back to PCOS main page
